PALO ALTO, Calif.--(BUSINESS WIRE)--Surf Bio, Inc., a biopharmaceutical company commercializing a novel drug stabilization platform, today announced a $16 million Series Seed round of funding. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results